Why under €200M can be a useful cut, and where it can mislead
Thresholds are blunt instruments, but they can still be useful. A sub-€200M issuer bucket often captures the part of the market where analyst coverage drops sharply and liquidity becomes episodic. That is exactly where insider information should have the highest marginal value.
The case for the threshold
Below €200M, several features tend to coincide:
- lower sell-side coverage,
- thinner institutional ownership,
- larger informational asymmetries,
- wider bid-ask spreads,
- greater sensitivity to idiosyncratic developments.
Put plainly, this is where a director buying shares can still surprise people.
There is also a practical portfolio-construction reason. A simple threshold is easier to monitor than rolling quintiles across multiple exchanges, especially for discretionary investors screening filings in real time. If the objective is to find the strongest part of the signal rather than publish a beautiful academic chart, “under €200M” is a decent first pass.
The case against fetishising the threshold
A €190M company on Euronext Growth and a €190M company on the main market are not the same animal. Nor is a €220M issuer necessarily more efficient than a €180M one. Market structure, free float, governance quality, and country-specific disclosure habits all matter.
Thresholds also drift with inflation and market regimes. A €200M cut in 2016 and the same nominal cut in 2026 do not identify exactly the same economic population. Quintiles solve some of that by defining smallness relative to the contemporaneous universe.
The right way to use the threshold is as an operational shortcut, not a law of nature.
Europe versus the US, same logic, different plumbing
The broad pattern, stronger insider-buy signal in smaller firms, appears in both Europe and the US, but the plumbing differs. In the US, Form 4 data are standardised and heavily mined. In Europe, MAR harmonised the framework, but local market practices and filing presentation still vary. That can slow market digestion and, paradoxically, preserve some of the edge.
France is a good example. The AMF sits within the MAR regime, so the legal timetable is common across the EU. Yet the practical visibility of directors’ dealings still depends on issuer communication, data vendors, and investor attention. In a small French issuer with limited coverage, the filing may remain underappreciated longer than an equivalent US large-cap Form 4.
What the literature says, and what it does not
The academic literature is broad enough to support the central claim, though not every paper uses the exact T+90 and quintile framing. The recurring findings are that insider purchases outperform sales as a signal, and that profitability is stronger in smaller, less-followed, and more difficult-to-value firms.
Purchases beat sales as a signal
This is one of the sturdier results in insider-trading research. Sales are noisy. Executives sell for taxes, diversification, school fees, divorce settlements, and the occasional yacht. Purchases are cleaner because people are generally less inclined to buy more of what already dominates their human-capital risk unless they think the price is wrong.
That asymmetry becomes sharper in small caps because the personal and reputational cost of buying into a weak issuer is higher, while the market’s baseline information is poorer.
Information opacity amplifies the effect
Studies across markets have linked stronger insider profitability to firms with higher information asymmetry, lower analyst following, and greater valuation uncertainty. Small caps score highly on all three. This is why the small-cap edge should not be interpreted as a pure “size effect”. It is more accurately an opacity effect that often rides inside the size bucket.
The literature is less helpful on implementation
Academic studies are excellent at documenting abnormal returns. They are less useful on the grubby details of actually trading the signal in a capacity-constrained portfolio. Bid-ask spreads, borrow constraints, stale pricing, and filing-normalisation errors matter a great deal in the lower-cap universe.
A paper can tell you that insider buys in small firms outperform over the next few months. It cannot guarantee that your fund can buy enough stock, at a reasonable spread, without becoming the market.